Noxtec designs, manufactures and supplies state-of-the-art medical devices worldwide.
Noxtec - part of Nippon Gases Pharma - over the years has developed extensive know-how in inhaled nitric oxide therapies, starting in neonatal intensive care units and then focusing on pediatric and adult patients, playing a key role during the treatment of Covid-19 patients.
Our goal is to develop new and different medical products to increase the quality of solutions delivered to healthcare providers and patients.